03 March 2018 1 9K Report

Most research papers I found only studied its effects on depression and Parkinson's disease rather than its ability to treat hyperpigmentation of the skin.

I am beginning to this that it may be useless to study its effect as a skin lightening injectable peptide.

So is the lack of studies covering this effect because it does not lighten the skin, or because it is common sense that a melanin inhibiting factor will lighten the skin and reduce hyperpigmentation, so no one studied it?

I have very limited fund and lab resources for this research from my institution, so I'm trying to invest them in something that will be ground-breaking.

It is important to mention that this peptide was effective in reducing pigmentation when applied topically, however, not much about hohow it affects the skin as an injectable peptide.

So does MIF-1 lighten the skin when injected into it? And why isn't there much research papers covering its ability to do so?

Thank you.

More Liam De Ka's questions See All
Similar questions and discussions